Ann Arbor, MI Should I have a hysterectomy and oophorectomy to treat...
Health Information Should I have a hysterectomy and oophorectomy to treat endometriosis?
Should I have a hysterectomy and oophorectomy to treat endometriosis?
Introduction
This information will
help you understand your choices, whether you share in the decision-making
process or rely on your doctor's recommendation.
Key points in making your decision
If you have
endometriosis, you probably already know that
estrogen "feeds" endometriosis growth. This is why
endometriosis only affects women during their high-estrogen adult years. When
your menstrual periods stop around age 50 (menopause) and
your estrogen levels drop, endometriosis growth and symptoms will probably also
stop (in some cases, endometriosis scar tissue remains after menopause and can
cause problems).
Consider the following when making your decision
about having your ovaries and uterus removed to control endometriosis:
There is no cure for endometriosis. Hormone
therapy or surgical removal of endometriosis tissue are commonly used to
relieve pain. But pain commonly returns within a year or two after
treatment.1
The ovaries produce most of
your body's estrogen. Removing the ovaries (oophorectomy) along
with the uterus (hysterectomy) is a last-resort treatment for
endometriosis. It does not offer a guaranteed cure-up to 15% of women have pain
that returns after this surgery.1
Hysterectomy with oophorectomy is a major
surgery with short-term and long-term risks. Recovery takes 4 to 6 weeks.
The sudden drop in estrogen after oophorectomy causes more severe
menopause symptoms than you would have with natural
menopause. The low estrogen also starts bone-thinning at a younger age. This
increases your risk of
osteoporosis later in life.
Some doctors
remove only one ovary when treating a younger woman with hysterectomy and
oophorectomy.
You have a second decision to make if you plan to
have an oophorectomy: whether to take
estrogen therapy. Taking estrogen therapy will protect
your bones and prevent menopause symptoms after your ovaries are removed. But
it may also cause endometriosis to grow back again.2
Hysterectomy and oophorectomy may be a good option if you do
not plan to be pregnant in the future, are not approaching menopause, have
severe symptoms, and feel that your symptom relief will outweigh the
risks and side effects of having the surgery.
For more information about whether to take estrogen
therapy, see:
The
endometrium is the tissue that lines the uterus.
During each menstrual cycle, a new endometrium grows, getting ready for a
possible pregnancy. If you don't become pregnant during that cycle, the
endometrium sheds, which you know as your
menstrual period.
Endometriosis is
endometrium tissue that grows outside of the uterus, usually on the
ovaries or
fallopian tubes or on the outer surface of the uterus,
the bowels, or other abdominal organs. In rare cases, it can affect other
organs and structures in the body.
Endometriosis growths are
called 'implants.' These implants grow, bleed, and break down with each
menstrual cycle, just like the endometrium does. This can cause pain and can
make it difficult to become pregnant (infertility). In some cases, scar tissue
forms around implants. Scar tissue can also cause pain and infertility and can
interfere with an organ's normal function.
What are the risks of endometriosis?
While some
women never have symptoms, others have severe pain. In some cases,
endometriosis interferes with other organs, such as the bowels or
bladder.
When is hysterectomy and removal of the ovaries an option for the treatment of endometriosis?
Hysterectomy and oophorectomy are
considered a last-resort treatment for endometriosis. This is because it is a
major surgery that results in permanent infertility, and removing the ovaries
causes a sudden drop in estrogen. This causes sudden, usually severe menopause,
difficult side effects, and bone-thinning. Normally, a woman takes low-dose
estrogen to prevent these problems after having an oophorectomy. But taking
estrogen may also increase the risk that endometriosis will return.
Hysterectomy and removal of the ovaries may be a treatment option
when:
Endometriosis symptoms decrease your quality
of life.
Scar tissue impairs the function of abdominal organs
(although scar tissue can usually be surgically removed without also taking the
uterus and ovaries).
You have tried treatment with hormone therapy and continue to
have pelvic pain or other symptoms.
You have no future plans for
childbearing.
Your symptoms outweigh the risks and long-term
effects of the surgery. This includes the long-term risks of taking
estrogen therapy to protect against bone-thinning
after your ovaries are removed versus the risk of osteoporosis if you don't
take estrogen therapy.
How effective is hysterectomy and removal of the ovaries for the treatment of endometriosis?
Oophorectomy and hysterectomy is
highly effective in relieving endometriosis pain.2
But pain does return for up to 15% of women.1 Your
risk of recurring endometriosis increases if you take low-dose estrogen to
protect your bones and prevent menopausal symptoms after surgery.2 This is because estrogen "feeds" endometriosis.
What are the risks of having an oophorectomy and hysterectomy?
After oophorectomy
Perhaps the most important
long-term issue to consider is your body's early drop in estrogen after an
oophorectomy. Without estrogen, you have difficult menopausal symptoms (hot flashes, vaginal dryness, moodiness,
depression), and your bones begin to thin. This
increases your risk of osteoporosis in later life. Taking estrogen therapy can
prevent these effects.
If you don't want to take estrogen, you
can take another type of bone-strengthening therapy to protect your bones after
oophorectomy. For more information on prevention, see the topic
Osteoporosis.
Risks of estrogen replacement therapy
Estrogen replacement therapy (ERT) increases your risks of:3
Stroke. ERT use slightly increases the
risk of stroke during the first year of use.4
Blood clots. ERT slightly increases the risk of blood clots in
the legs (deep vein thrombosis) and lungs (pulmonary embolism), which can be life-threatening.
This risk is greatest in the first year of use.5
Breast cancer. Research is mixed on breast cancer
risk, although a slightly increased breast cancer risk after 10 years of use is
possible.6, 7
Gallstones. Women who use estrogen
replacement therapy are 2 to 3 times more likely to have gallstones than women
who do not use it.8
Asthma. Newly diagnosed asthma appears to be more
common among women taking estrogen than women who are not. (Estrogen is thought
to be a factor that causes asthma or makes it worse across the life
span.)9
In some cases, a worsening of
endometriosis.
Ovarian cancer (which is rare). In women using ERT over 5
years, the number of ovarian cancers is slightly higher. Using ERT causes
ovarian cancer in about .4 per 1,000 women. (This is the same as 1 in 2,500
women.)10
After hysterectomy
Most women do not have
complications after a hysterectomy. But complications can include:
Fever. A slight fever is common after any
surgery.
Difficulty urinating.
Continued
heavy bleeding. Some vaginal bleeding within 4 to 6
weeks after a hysterectomy is expected. But call your health professional if
bleeding continues to be heavy.
Continued pain. Pelvic pain that
was present before surgery may not be relieved by surgery.
Change
in sexual function.
Rare complications. These include infection;
blood clots in the legs (thrombophlebitis) or in the lungs
(pulmonary embolus); the formation of scar tissue; injury to other organs, such
as the bladder or bowel; a collection of blood at the surgical site (hematoma);
heart problems; breathing problems; and problems from anesthesia. In very rare
cases, complications from surgery lead to death.
If you need more information, see the topic
Endometriosis.
Your Information
Your choices are:
Have a hysterectomy and oophorectomy to treat
symptoms caused by endometriosis.
Continue to use more conservative
measures, such as hormone therapy to treat endometriosis or
laparoscopic surgery to remove endometriosis and scar
tissue.
The decision about whether to have a hysterectomy takes
into account your personal feelings and the medical facts.
Deciding about hysterectomy and oophorectomy
Reasons to have a
hysterectomy and oophorectomy
Reasons not to have a
hysterectomy and oophorectomy
Symptoms of endometriosis are severe and
are decreasing your quality of life.
Treatment with medicine has
not controlled your symptoms.
You want no future
pregnancies.
You are not going to experience natural menopause for
many years. (After menopause, symptoms usually go away.)
The
function of abdominal organs, such as the bladder or bowels, is impaired
because of scar tissue (adhesions).
Your symptoms are severe enough
to outweigh the side effects and long-term risks of the surgery.
Are there other reasons that you might want to have a
hysterectomy?
Symptoms of endometriosis are not severe
or are not decreasing your quality of life.
Home treatment methods
effectively relieve your pain.
You have not tried hormone therapy
and surgical removal of scar tissue and implants to control your
symptoms.
You have tried hormone therapy (such as birth control
pills or danazol) with some success, and the side effects are
tolerable.
You may want to become pregnant in the
future.
You are approaching menopause (around age 50). After
menopause, symptoms usually go away.
Your symptoms are not severe
enough to outweigh the side effects and long-term risks of the surgery.
Are there other reasons that you might not want to
have a hysterectomy?
Use this worksheet to help you make your decision.
After completing it, you should have a better idea of how you feel about having
an oophorectomy and hysterectomy to treat endometriosis. Discuss the worksheet
with your doctor.
Circle the answer that best applies to
you.
I have severe symptoms of endometriosis.
Yes
No
Unsure
My symptoms are gradually getting worse.
Yes
No
Unsure
I have pain during intercourse.
Yes
No
Unsure
I have painful urination, blood in my urine, or an
inability to control the flow of my urine.
Yes
No
Unsure
I wish to become pregnant.
Yes
No
Unsure
I am approaching menopause.
Yes
No
Unsure
Treatment with prescription medicines, such as
birth control pills, leuprolide (Lupron, for example), or danazol, has relieved
my symptoms.
Yes
No
NA*
I have other medical conditions, such as kidney
failure, liver failure, or a bleeding disorder, that would make surgery
risky.
Yes
No
Unsure
I have a strong family history of osteoporosis,
which puts me at high risk if my ovaries are removed early.
Yes
No
Unsure
I have risk factors that would keep me from taking
estrogen replacement therapy after an oophorectomy, such as having had a blood
clot in my legs or lungs.
Yes
No
Unsure
*NA = Not applicable
Use the following space to list any other important concerns you have
about this decision.
What is your overall impression?
Your answers in
the above worksheet are meant to give you a general idea of where you stand on
this decision. You may have one overriding reason to have or not have an
oophorectomy and hysterectomy.
Check the box below that represents
your overall impression about your decision.
Leaning toward having an oophorectomy and hysterectomy
Leaning toward NOT having an oophorectomy and hysterectomy
American College of Obstetricians and Gynecologists
(1999). Medical management of endometriosis. ACOG Practice Bulletin No. 11.
Obstetrics and Gynecology, 94(6): 1-14.
Speroff L, Fritz MA (2005). Endometriosis. In
Clinical Gynecologic Endocrinology and Infertility, 7th
ed., pp. 1103-1133. Philadelphia: Lippincott Williams and Wilkins.
Rossouw JE, et al. (2002). Risks and benefits of
estrogen plus progestin in healthy postmenopausal women. Principal results from
the Women's Health Initiative randomized controlled trial. JAMA, 288(3): 321-333.
American College of Obstetricians and Gynecologists
Women's Health Care Physicians (2004). Stroke. Obstetrics and Gynecology, 104(4, Suppl): 97S-105S.
American College of Obstetricians and Gynecologists
Women's Health Care Physicians (2004). Venous thromboembolic disease.
Obstetrics and Gynecology, 104(4, Suppl):
118S-127S.
Million Women Study Collaborators (2003). Breast
cancer and hormone-replacement therapy in the Million Women Study.
Lancet, 362(9382): 419-427.
Women's Health Initiative Steering Committee (2004).
Effects of conjugated equine estrogen in postmenopausal women with
hysterectomy. JAMA, 291(14): 1701-1712.
Hammond C (1999). Climacteric. In JR Scott et al., eds., Danforth's Obstetrics and Gynecology, 8th ed., pp. 677-697.
Philadelphia: Lippincott Williams and Wilkins.
Barr RG, et al. (2004). Prospective study of
postmenopausal hormone use and newly diagnosed asthma and chronic obstructive
pulmonary disease. Archives of Internal Medicine,
164(4): 379-386.
Beral V, et al. (2007). Ovarian cancer and hormone
replacement therapy in the Million Women Study. Lancet,
369(9574): 1703-1710.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
American College of Obstetricians and Gynecologists
(1999). Medical management of endometriosis. ACOG Practice Bulletin No. 11.
Obstetrics and Gynecology, 94(6): 1-14.
Speroff L, Fritz MA (2005). Endometriosis. In
Clinical Gynecologic Endocrinology and Infertility, 7th
ed., pp. 1103-1133. Philadelphia: Lippincott Williams and Wilkins.
Rossouw JE, et al. (2002). Risks and benefits of
estrogen plus progestin in healthy postmenopausal women. Principal results from
the Women's Health Initiative randomized controlled trial. JAMA, 288(3): 321-333.
American College of Obstetricians and Gynecologists
Women's Health Care Physicians (2004). Stroke. Obstetrics and Gynecology, 104(4, Suppl): 97S-105S.
American College of Obstetricians and Gynecologists
Women's Health Care Physicians (2004). Venous thromboembolic disease.
Obstetrics and Gynecology, 104(4, Suppl):
118S-127S.
Million Women Study Collaborators (2003). Breast
cancer and hormone-replacement therapy in the Million Women Study.
Lancet, 362(9382): 419-427.
Women's Health Initiative Steering Committee (2004).
Effects of conjugated equine estrogen in postmenopausal women with
hysterectomy. JAMA, 291(14): 1701-1712.
Hammond C (1999). Climacteric. In JR Scott et al., eds., Danforth's Obstetrics and Gynecology, 8th ed., pp. 677-697.
Philadelphia: Lippincott Williams and Wilkins.
Barr RG, et al. (2004). Prospective study of
postmenopausal hormone use and newly diagnosed asthma and chronic obstructive
pulmonary disease. Archives of Internal Medicine,
164(4): 379-386.
Beral V, et al. (2007). Ovarian cancer and hormone
replacement therapy in the Million Women Study. Lancet,
369(9574): 1703-1710.